OpGen, Inc. (NASDAQ:OPGN) will be discussing 3Q20 financial results with the investment community.on 11th November 2020 at 4:30 PM eastern time.
Those interested in listening to the conference call live via the Internet can visit www.opgen.com
Earnings Expectation
OpGen, Inc. is reporting third quarter earnings results on Wednesday 11th November 2020, after market close.
The consensus estimates from Thomson Reuters are loss of $ 0.36 per share from $ 1.00 million in revenue. For the full year, analysts predict revenues of $ 4.29 million, while looking forward to loss of $ 1.62 per share.
The Company Outlook
Revenue for 3Q20 are expected in a range of $ 1.00 million ~ $ 1.00 million
Click Here For More Historical Outlooks Of OpGen, Inc.
OpGen, Inc., a precision medicine company, engages in developing molecular information products and services to combat infectious diseases in the United States and internationally. The company utilizes molecular diagnostics and informatics to help combat infectious diseases. It also helps clinicians with information about life threatening infections, enhance patient outcomes, and decrease the spread of infections caused by multidrug-resistant microorganisms.
